RakshaJainMD
Pulmonology • Dallas, TXCritical Care Medicine, Pleural Disease
Associate Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School
Dr. Jain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Stop 8558
Dallas, TX 75390Phone+1 214-648-2546Fax+1 214-648-2555
Summary
- Dr. Raksha Jain is a board certified pulmonary and critical care physician in Dallas, TX and is affiliated with multiple hospitals in the area, including University of Texas Southwestern Medical Center and Children's Medical Center Dallas. She received her medical degree from University of Texas Houston Health Science Center, completed Internal Medicine residency at UT Southwestern and Pulmonary and Critical Care fellowship along with a Masters of Science in Clinical Investigation at Washington University. She is also a physician scientist and specializes in bronchiectasis and cystic fibrosis.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2006 - 2009
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2001 - 2005
McGovern Medical School at UTHealthClass of 2001
Certifications & Licensure
NM State Medical License 2023 - 2026
TX State Medical License 2003 - 2026
LA State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) Start of enrollment: 2014 Jan 01
- Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis Start of enrollment: 2013 Jun 01
- Gender Disparity and Hormones in Cystic Fibrosis Start of enrollment: 2014 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Lentiviral Gene Therapy for Cystic Fibrosis: A Promising Approach and First-in-Human Trial.Jane C Davies, Deepika Polineni, A Christopher Boyd, Scott Donaldson, Deborah R Gill
American Journal of Respiratory and Critical Care Medicine. 2024-12-15 - Outcomes in Black People with Cystic Fibrosis: A Registry Analysis.Sunjay R Devarajan, Kristen A Staggers, Tianshi D Wu, Raksha Jain
Annals of the American Thoracic Society. 2024-12-01 - 1 citationsImpact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis.Nicole Mayer-Hamblett, Alex H Gifford, Margaret Kloster, Renee Russell, Andrew T Braun
Annals of the American Thoracic Society. 2024-11-01
Journal Articles
- Antimicrobial Susceptibility Study Ceftolozane/tazobactam Sensitivity Patterns in Pseudomonas Aeruginosa Isolates Recovered from Sputum of Cystic Fibrosis PatientsJames D Finklea, Raksha Jain, Karen Lowe, Francesca Lee, ScienceDirect
Press Mentions
Gene-Editing Nanoparticles Correct Stem Cell Mutations in Cystic Fibrosis ModelsJune 26th, 2024
Young Professional Opens up About His Journey with Cystic FibrosisJanuary 16th, 2020
Three-Drug Combo Improves Lung Function in Patients with Cystic FibrosisNovember 26th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
